Skip to main content

Advertisement

SpringerLink
Log in

Exosome-Transmitted miR-506-3p Inhibits Colorectal Cancer Cell Malignancy via Regulating GSTP1

  • Original Article
  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Exosome-mediated microRNA transfer has been shown to regulate cancer progression. However, the involvement of exosomal-miR-506-3p in colorectal cancer (CRC) is unknown. The goal of the research was to study into the role of exosomal-miR-506-3p in CRC. Using a qRT-PCR experiment, it was observed that CRC tissues had lower levels of miR-506-3p than non-tumor tissues. It was observed that miR-506-3p inhibited the proliferation, regulates apoptosis, and cell cycle of HT29 and SW480 cells as compared to control groups. Dual luciferase reporter assay results showed that GSTP1 was the downstream target molecule of miR-506-3p, which was consistent with the database prediction. Furthermore, FHC cells transfected with miR-506-3p could transfer miR-506-3p to SW480 cells, limiting cell growth and inducing cell death. We discovered a unique regulatory mechanism in which exosome-mediated transfer of miR-506-3p reduces proliferation and induces apoptosis in CRC through negative regulation of GSTP1, implying that exosome-mediated delivery of miR-506-3p provides fresh insight into CRC diagnostics and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data Availability

All data and materials in the manuscript will be made available by the corresponding authors.

References

  1. Duan, L., et al. (2020). Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer. Therapeutic Advances in Medical Oncology, 12, 1758835920947342.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Goldberg, R. (2005). Advances in the treatment of metastatic colorectal cancer. Oncologist, 10(Suppl 3), 40–8.

    Article  CAS  PubMed  Google Scholar 

  3. Luo, M., et al. (2021). Drug resistance in colorectal cancer: An epigenetic overview. Biochimica et biophysica acta. Reviews on Cancer, 1876(2), 188623.

  4. Cardeñes, B., et al. (2021). Cellular integrin α5β1 and exosomal ADAM17 mediate the binding and uptake of exosomes produced by colorectal carcinoma cells. International Journal of Molecular Sciences, 22(18), 9938.

  5. Nabariya, D., Pallu, R., & Yenuganti, V. (2020). Exosomes: The protagonists in the tale of colorectal cancer? Biochimica et biophysica acta. Reviews on cancer, 1874(2), 188426.

    CAS  PubMed  Google Scholar 

  6. Del Pozo-Acebo, L., et al. (2021). Bovine milk-derived exosomes as a drug delivery vehicle for miRNA-based therapy. International Journal of Molecular Sciences, 22(3), 1105.

  7. Gao, Q., et al. (2020). Functional passenger-strand miRNAs in exosomes derived from human colon cancer cells and their heterogeneous paracrine effects. International Journal of Biological Sciences, 16(6), 1044–1058.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Zhang, Y., Ma, L., & Xie, Y. (2020). MiRNA-802 inhibits the metastasis of colorectal cancer by targeting FOXE1. European Review for Medical and Pharmacological Sciences, 24(4), 1778–1785.

    CAS  PubMed  Google Scholar 

  9. Zhao, M., et al. (2021). miR-107 regulates the effect of MCM7 on the proliferation and apoptosis of colorectal cancer via the PAK2 pathway. Biochemical Pharmacology, 190, 114610.

    Article  CAS  PubMed  Google Scholar 

  10. Tian, F., et al. (2021). Exosome-delivered miR-221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer. Cancer Science, 112(9), 3744–3755.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shang, A., et al. (2020). Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1. Aging, 12(9), 8352–8371.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chen, Y., et al. (2020). Serum exosomes derived from Hp-positive gastritis patients inhibit MCP-1 and MIP-1α expression via NLRP12-Notch signaling pathway in intestinal epithelial cells and improve DSS-induced colitis in mice. International immunopharmacology, 88, 107012.

    Article  CAS  PubMed  Google Scholar 

  13. Fu, X., et al. (2018). KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma. International Journal of Oncology, 52(6), 1912–1922.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Xia, Y., et al. (2020). Exosome-mediated transfer of miR-1260b promotes cell invasion through Wnt/β-catenin signaling pathway in lung adenocarcinoma. Journal of Cellular Physiology, 235(10), 6843–6853.

    Article  CAS  PubMed  Google Scholar 

  15. Logozzi, M., et al. (2009). High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One, 4(4), e5219.

  16. Clancy, C., Joyce, M., & Kerin, M. (2015). The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer. Cancer Biomarkers : Section A of Disease Markers, 15(2), 103–113.

    Article  CAS  PubMed  Google Scholar 

  17. Li, J., et al. (2018). Suppression of Capn4 by microRNA-1271 impedes the proliferation and invasion of colorectal cancer cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 99, 162–168.

  18. Ganju, A., et al. (2017). miRNA nanotherapeutics for cancer. Drug Discovery Today, 22(2), 424–432.

    Article  CAS  PubMed  Google Scholar 

  19. Li, C., et al. (2021). Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis. Human cell, 34(4), 1255–1265.

    Article  CAS  PubMed  Google Scholar 

  20. Zhou, M., et al. (2021). LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells. Eur Arch Otorhinolaryngol, 278(9), 3363–3374.

    Article  PubMed  Google Scholar 

  21. Liang, T., et al. (2019). MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2. Journal of Experimental & Clinical Cancer Research : CR, 38(1), 97.

    Article  PubMed Central  Google Scholar 

  22. Fu, X., et al. (2021). Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of the miR-506-3p/ZEB2/EMT axis. American Journal of Cancer Research, 11(8), 3841–3856.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Lin, C., et al. (2018). miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells. International Journal of Molecular Medicine, 41(4), 2050–2058.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Zeng, Q., Lu, H., & Wang, X. (2005). Molecular characterization of a glutathione transferase from Pinus tabulaeformis (Pinaceae). Biochimie, 87(5), 445–455.

    Article  CAS  PubMed  Google Scholar 

  25. Cullen, K., et al. (2003). Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Research, 63(23), 8097–8102.

    CAS  PubMed  Google Scholar 

  26. Song, B., et al. (2019). Combined detection of HER2, Ki67, and GSTP1 genes on the diagnosis and prognosis of breast cancer. Cancer Biotherapy & Radiopharmaceuticals, 34(2), 85–90.

    Article  CAS  Google Scholar 

  27. Puerta-García, E., et al. (2020). Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma. Surgical Oncology, 35, 388–398.

    Article  PubMed  Google Scholar 

  28. Wang, X., et al. (2020). Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Molecular Oncology, 14(3), 539–555.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China (Grant No. 81802372), the Natural Science Foundation of Hebei Province (Grant Nos. H2020107005 and H2020107002), and the Scientific and Technological Project of the Hebei Province of China (Grant No. 14397702D).

Author information

Author notes

  1. Bin Xuan

    Present address: Department of General Surgery, The First Hospital of Qinhuangdao, Qinhuangdao, China

Authors and Affiliations

  1. Department of Surgical, Hebei Medical University, Shijiazhuang, Hebei Province, China

    Bin Xuan & Yimin Wang

  2. Department of General Surgery, The First Hospital of Qinhuangdao, Qinhuangdao, China

    Yimin Wang

Authors
  1. Bin Xuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yimin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

B. X.: writing, conceptualization, methodology, software.

B. X.: and Y. W.: data curation, writing, original draft preparation.

Y. W.: reviewing and editing.

Corresponding author

Correspondence to Yimin Wang.

Ethics declarations

Ethical Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xuan, B., Wang, Y. Exosome-Transmitted miR-506-3p Inhibits Colorectal Cancer Cell Malignancy via Regulating GSTP1. Appl Biochem Biotechnol 195, 2015–2027 (2023). https://doi.org/10.1007/s12010-022-04268-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-022-04268-x

Keywords

Search

Navigation